GB928150A - Topical pharmaceutical compositions comprising steroids and flavonoids - Google Patents
Topical pharmaceutical compositions comprising steroids and flavonoidsInfo
- Publication number
- GB928150A GB928150A GB45269/61A GB4526961A GB928150A GB 928150 A GB928150 A GB 928150A GB 45269/61 A GB45269/61 A GB 45269/61A GB 4526961 A GB4526961 A GB 4526961A GB 928150 A GB928150 A GB 928150A
- Authority
- GB
- United Kingdom
- Prior art keywords
- radical
- carbon atoms
- pharmaceutical compositions
- group contains
- topical application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Pharmaceutical compositions for topical application comprise a carrier and a flavone or 2,3-dihydroflavone of general formula <FORM:0928150/VI/1> or <FORM:0928150/VI/2> wherein each of R1 to R10 may represent a hydrogen atom or a hydroxy radical or an alkoxy radical in which the alkyl group contains from 1 to 4 carbon atoms or an axyloxy radical in which the acyl group contains from 1 to 5 carbon atoms in admixture with a steroid of the pregnane (C21 nucleus) series having topical anti-inflammatory activity according to a specified test, e.g. cortisone, prednisone and prednisolone and derivatives thereof including halogen derivatives, alkali metal phosphates, hydrocarbon dicarboxylic acid 21-hemi-esters and their water-soluble salts, many specific examples of which are given. The compositions may be in conventional forms suitable for topical application, e.g. ointments, lotions, creams, nasal sprays, drops, suppositories, aerosols, and powders which may optionally also comprise antibiotics, e.g. neomycin, tetracyclines, novobiocin, erthromycin, penicillin, chloramphenicol, streptomycin, bacitracin, polymyxin, tyrothrycin and gramicidin; antifungal agents, e.g. iodochlorohydroxyquin, filipin and nystatin; vasoconstrictors, e.g. phenylephrine and isoproterenol and the local an sthetics, e.g. procaine, phenocaine, tetracaine, lidocaine, primoxine and ethylaminobenzoate.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8775161A | 1961-02-08 | 1961-02-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB928150A true GB928150A (en) | 1963-06-06 |
Family
ID=22207030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB45269/61A Expired GB928150A (en) | 1961-02-08 | 1961-12-18 | Topical pharmaceutical compositions comprising steroids and flavonoids |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE613613A (en) |
FR (1) | FR1751M (en) |
GB (1) | GB928150A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4158055A (en) * | 1973-08-17 | 1979-06-12 | American Cyanamid Company | Administration of 16α,17α-cyclopentylidenedioxy-9α-fluor O-11β,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate |
US5629339A (en) * | 1994-10-26 | 1997-05-13 | Adir Et Compagnie | Diosmetin compounds |
-
1961
- 1961-12-18 GB GB45269/61A patent/GB928150A/en not_active Expired
-
1962
- 1962-02-07 BE BE613613A patent/BE613613A/en unknown
- 1962-02-07 FR FR887297A patent/FR1751M/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4158055A (en) * | 1973-08-17 | 1979-06-12 | American Cyanamid Company | Administration of 16α,17α-cyclopentylidenedioxy-9α-fluor O-11β,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate |
US5629339A (en) * | 1994-10-26 | 1997-05-13 | Adir Et Compagnie | Diosmetin compounds |
Also Published As
Publication number | Publication date |
---|---|
FR1751M (en) | 1963-04-01 |
BE613613A (en) | 1962-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Babcock et al. | 6α-Methyl-17α-HYDROXYPROGESTERONE 17-ACYLATES; A NEW CLASS OF POTENT PROGESTINS1 | |
GB1151404A (en) | Novel Gona-1,3,5(10)-Trienes, Processes for their Preparation, and Compositions incorporating them | |
GB928150A (en) | Topical pharmaceutical compositions comprising steroids and flavonoids | |
GB902293A (en) | Improvements in or relating to steroids and the manufacture thereof | |
GB1211219A (en) | 21-aldehydes of the pregnane series and derivatives thereof and process for their manufacture | |
GB901093A (en) | Steroids | |
Benn | A Reinvestigation of the Synthesis of 5, 16-Pregnadiene-3β, 20α-diol. The Nuclear Magnetic Resonance Spectra of Some Epimeric 20-Hydroxypregnane Derivatives | |
HOSODA et al. | Synthesis of corticosteroid haptens possessing the bridge at the C-4 position | |
GB1277266A (en) | 07-acetylgonanes and derivatives therefor | |
US3365473A (en) | 13beta-lower alkyl gona-4, 8(14)-dien-3-ones 17 beta process for the production thereof | |
GB959378A (en) | 21-substituted 17ª, 21-dioxy steroids and processes for their preparation | |
US3301876A (en) | 2/3-oxygenated-2/3-thiocyanato-5alpha-androstan-17-ones and derivatives thereof | |
ALLEN Jr et al. | The synthesis of 16α-methoxyhydrocortisone acetate and congeners | |
US3153060A (en) | Enol ethers of 6-methyl-3-oxo-4, 6-dienic steroids | |
US3017419A (en) | 11alpha-methyl-androstane derivatives | |
GB996079A (en) | 17ª‡,21-substituted methylenedioxy steroids and methods therefor | |
GB1029439A (en) | í¸-3-hydroxy-steroids and derivatives thereof | |
GB1061236A (en) | Pharmaceutical compositions comprising anti-inflammatory steroids and anti-viral nucleosides | |
GB1512761A (en) | Estra-1,3,5,(10)-triene a process for its preparation and pharmaceutical compositions containing it | |
Okada et al. | In Vitro Metabolism of 17α-Methyl-1 9-Nortestosterone by Female Rat Liver Homogenate | |
GB1104725A (en) | New steroid compounds useful as intermediates in the preparation of 9ª‡-fluoro steroids | |
GB1192061A (en) | Steroidal 1,4-Dienes | |
GB1087730A (en) | Novel steroid-21-esters, processes for their preparation, and pharmaceutical compositions containing them | |
GB1149503A (en) | Improvements in or relating to 19-fluoro-19-oxo-derivatives of androstane and pregnane | |
GB1272688A (en) | Sulphamido-steroids and the preparation thereof |